Recommendations for evaluating the safety of medicinal products containing nanoparticles
Recommendations for preclinical safety assessment of medicinal products containing nanoparticles are presented. The recommendations provide conditions for research acute and chronic toxicity of nanotherapeutics, methods for their quantitative and qualitative assessments.
Saved in:
| Main Authors: | R. N. Alyautdin, B. K. Romanov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-02-01
|
| Series: | Безопасность и риск фармакотерапии |
| Subjects: | |
| Online Access: | https://www.risksafety.ru/jour/article/view/25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Guidelines for the Preparation of a Document Containing the Drug Safety Monitoring Results
by: Yu. V. Olefir, et al.
Published: (2018-02-01) -
Recommendations on the procedure for determining the interchangeability of medicinal products
by: B. K. Romanov, et al.
Published: (2018-02-01) -
Guidelines for the planning and implementation of pharmacovigilance systems audit
by: S. V. Glagolev, et al.
Published: (2018-02-01) -
Perfection of management principles by the safety signals of medicinal products
by: B. K. Romanov, et al.
Published: (2018-02-01) -
Pitfalls of patenting and state authorization of medicines
by: V. I. Semenov, et al.
Published: (2018-02-01)